| EANM procedure guidelines for therapy of benign thyroid disease MPM Stokkel, D Handkiewicz Junak, M Lassmann, M Dietlein, M Luster European journal of nuclear medicine and molecular imaging 37, 2218-2228, 2010 | 262 | 2010 |
| Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review B Jarzab, D Handkiewicz-Junak, J Włoch Endocrine-related cancer 12 (4), 773-803, 2005 | 257 | 2005 |
| Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer D Handkiewicz-Junak, J Wloch, J Roskosz, J Krajewska, A Kropinska, ... Journal of Nuclear Medicine 48 (6), 879-888, 2007 | 240 | 2007 |
| Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children B Jarząb, DH Junak, J Włoch, B Kalemba, J Roskosz, A Kukulska, Z Puch European journal of nuclear medicine 27, 833-841, 2000 | 223 | 2000 |
| Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions D Handkiewicz-Junak, A Czarniecka, B Jarząb Molecular and cellular endocrinology 322 (1-2), 8-28, 2010 | 170 | 2010 |
| European perspective on 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: proceedings of an … M Luster, C Aktolun, I Amendoeira, M Barczyński, KC Bible, LH Duntas, ... Thyroid 29 (1), 7-26, 2019 | 159 | 2019 |
| 90Y–DOTA–D‐Phe1–Try3– octreotide in therapy of neuroendocrine malignancies G Paganelli, L Bodei, D Handkiewicz Junak, P Rocca, S Papi, ... Peptide Science: Original Research on Biomolecules 66 (6), 393-398, 2002 | 159 | 2002 |
| EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer TD Poeppel, D Handkiewicz-Junak, M Andreeff, A Becherer, A Bockisch, ... European journal of nuclear medicine and molecular imaging 45, 824-845, 2018 | 138 | 2018 |
| Receptor radionuclide therapy with 90Y-DOTATOC in patients with medullary thyroid carcinomas L Bodei, D Handkiewicz-Junak, C Grana, C Mazzetta, P Rocca, ... Cancer biotherapy and radiopharmaceuticals 19 (1), 65-71, 2004 | 120 | 2004 |
| Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours) B Kos-Kudła, J Blicharz-Dorniak, J Strzelczyk, A Bałdys-Waligórska, ... Endokrynologia Polska 68 (2), 79-110, 2017 | 119 | 2017 |
| Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients B Jarząb, D Handkiewicz-Junak, J Roskosz, Z Puch, Z Wygoda, ... European Journal of Nuclear Medicine and Molecular Imaging 30, 1077-1086, 2003 | 103 | 2003 |
| 2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer? F Pacini, D Fuhrer, R Elisei, D Handkiewicz-Junak, S Leboulleux, ... European Thyroid Journal 11 (1), 2022 | 94 | 2022 |
| Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi A Kukulska, J Krajewska, M Gawkowska-Suwińska, Z Puch, ... Thyroid research 3, 1-4, 2010 | 88 | 2010 |
| Differentiated thyroid cancer in children and adults: same or distinct disease? B Jarzab, D Handkiewicz-Junak HORMONES-ATHENS- 6 (3), 200, 2007 | 87 | 2007 |
| EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides D Handkiewicz-Junak, TD Poeppel, L Bodei, C Aktolun, S Ezziddin, ... European journal of nuclear medicine and molecular imaging 45, 846-859, 2018 | 81 | 2018 |
| Gene signature of the post-Chernobyl papillary thyroid cancer D Handkiewicz-Junak, M Swierniak, D Rusinek, M Oczko-Wojciechowska, ... European journal of nuclear medicine and molecular imaging 43, 1267-1277, 2016 | 79 | 2016 |
| Combined treatment of glioblastoma patients with locoregional pre-targeted 90Y-biotin radioimmunotherapy and temozolomide M Bartolomei, C Mazzetta, D Handkiewicz-Junak, L Bodei, P Rocca, ... Quarterly Journal of Nuclear Medicine and Molecular Imaging 48 (3), 220-228, 2004 | 75 | 2004 |
| 13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single … D Handkiewicz-Junak, J Roskosz, K Hasse-Lazar, S Szpak-Ulczok, ... Thyroid research 2, 1-11, 2009 | 70 | 2009 |
| Recombinant thyrotropin use in children and adolescents with differentiated thyroid cancer: a multicenter retrospective study M Luster, D Handkiewicz-Junak, A Grossi, M Zacharin, D Taïeb, O Cruz, ... The Journal of Clinical Endocrinology & Metabolism 94 (10), 3948-3953, 2009 | 67 | 2009 |
| Guidelines of Polish National Societies diagnostics and treatment of thyroid carcinoma. 2018 update B Jarząb, M Dedecjus, D Słowińska-Klencka, A Lewiński, Z Adamczewski, ... Endokrynologia Polska 69 (1), 34-74, 2018 | 63 | 2018 |
